JACOBS LEVY EQUITY MANAGEMENT, INC - BIOHAVEN PHARMACTL HLDG CO L ownership

Back to all holdings Add to watchlist

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 226 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2021. The put-call ratio across all filers is 1.62 and the average weighting 0.7%.

Filings

EDGAR links

External links

Quarter-by-quarter ownership

JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of BIOHAVEN PHARMACTL HLDG CO L
	Value		Shares		Weighting
Q4 2020	$223,000	-95.9%	2,601	-96.9%	0.00%	-96.4%
Q3 2020	$5,433,000	+31.9%	83,565	+48.3%	0.06%	+24.4%
Q2 2020	$4,119,000	+106.2%	56,335	-4.0%	0.04%	+73.1%
Q1 2020	$1,998,000	–	58,701	–	0.03%	–
Download

Other shareholders

BIOHAVEN PHARMACTL HLDG CO L shareholders Q1 2021
Name	Shares	Value	Weighting ↓
Knoll Capital Management, LLC	450,422	$6,251,857	14.11%
Liontrust Investment Partners LLP	134,659	$7,478,961	0.13%
Birchview Capital, LP	7,365	$102	0.07%
FNY Investment Advisers, LLC	250	$3	0.00%
FNY Investment Advisers, LLC	18	$0	0.00%
FNY Investment Advisers, LLC	56	$0	0.00%
McElhenny Sheffield Capital Management, LLC	31	$430	0.00%
Blue Trust, Inc.	65	$10	0.00%
IFP Advisors, Inc	1	$1	0.00%

View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders